Foghorn Therapeutics to Participate in Upcoming Investor Conferences in June
Foghorn Therapeutics (Nasdaq: FHTX), a clinical-stage biotech company focused on treating serious diseases by correcting abnormal gene expression, announced its participation in two major investor conferences in June 2024. The Jefferies Global Healthcare Conference will feature Adrian Gottschalk, CEO, presenting on June 5, 2024, at 3:30 p.m. ET in New York. The Goldman Sachs 45th Annual Global Healthcare Conference will also include a presentation by Gottschalk on June 10, 2024, at 3:20 p.m. ET in Miami Beach. Both presentations will be accessible via webcast for 30 days on the company's website.
- Participation in high-profile conferences increases visibility and potential investor interest.
- Webcast availability allows broader investor access to presentations.
- CEO involvement can provide confidence to investors about the company's leadership and direction.
- No new financial or clinical data were announced, which may leave investors seeking more substantial updates.
- The market may perceive the announcements as routine, potentially leading to little impact on stock performance.
CAMBRIDGE, Mass., May 28, 2024 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced management's participation in the Jefferies Global Healthcare Conference and the Goldman Sachs 45th Annual Global Healthcare Conference. With an initial focus in oncology, Foghorn’s Gene Traffic Control® platform and resulting broad pipeline have the potential to transform the lives of people suffering from a wide spectrum of diseases.
Jefferies Global Healthcare Conference
- Presentation: Wednesday, June 5, 2024, at 3:30 p.m. ET at the Marriott Marquis New York, New York
- Foghorn Presenter: Adrian Gottschalk, President and Chief Executive Officer
- Please find a link to the webcast here
- Management will also participate in one-on-one meetings on Wednesday, June 5
Goldman Sachs 45th Annual Global Healthcare Conference
- Presentation: Monday, June 10, 2024, at 3:20 p.m. ET at the Loews Miami Beach Hotel, Miami Beach, Florida
- Foghorn Presenter: Adrian Gottschalk, President and Chief Executive Officer
- Please find a link to the webcast here
- Management will also participate in one-on-one meetings during the conference
A webcast of both presentations can be accessed under “Events & Presentations” in the Investors section of the Company’s website, www.foghorntx.com, and will be available for 30 days.
About Foghorn Therapeutics
Foghorn® Therapeutics is discovering and developing a novel class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Through its proprietary scalable Gene Traffic Control® platform, Foghorn is systematically studying, identifying and validating potential drug targets within the chromatin regulatory system. The Company is developing multiple product candidates in oncology. Visit our website at www.foghorntx.com for more information about the Company, and follow us on X (formerly Twitter) and LinkedIn.
Contacts:
Greg Dearborn, Foghorn Therapeutics Inc. (Investors)
gdearborn@foghorntx.com
Karin Hellsvik, Foghorn Therapeutics Inc. (Investors & Media)
khellsvik@foghorntx.com
Adam Silverstein, ScientPR (Media)
adam@scientpr.com
FAQ
When is Foghorn Therapeutics presenting at the Jefferies Global Healthcare Conference?
Where is the Jefferies Global Healthcare Conference being held?
Who will present at the Jefferies Global Healthcare Conference for Foghorn Therapeutics?
When is Foghorn Therapeutics presenting at the Goldman Sachs Annual Global Healthcare Conference?
Where is the Goldman Sachs 45th Annual Global Healthcare Conference being held?
How can I access the webcasts of Foghorn Therapeutics' presentations?
How long will the webcasts of Foghorn Therapeutics' presentations be available?
What is the stock symbol for Foghorn Therapeutics?
